ArticleNeurogastroenterology and motility2018

Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients.

E K Stern et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.